Interleukin-6, C-reactive protein and biochemical parameters during prolonged intermittent fasting

Annals of Nutrition and Metabolism

Volumn 51, Issue 1, 2007, Pages 88-95

  Aksungar, Fehime B ^a   Topkaya, Aynur E ^a   Akyildiz, Mahmut ^a  

^a MALTEPE UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Fasting; Folate; High density lipoprotein; Homocysteine; Interleukin 6; Ramadan; Vitamin B12

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOOD INTAKE; HUMAN; MALE; MOSLEM; NORMAL HUMAN; PRIORITY JOURNAL; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL; VENOUS BLOOD;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FASTING; FEMALE; HOMOCYSTEINE; HUMANS; INTERLEUKIN-6; LIPIDS; MALE; VITAMIN B COMPLEX;

EID: 34247483580     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100954     Document Type: Article

References (29)

1. Bogdan A, Bouchareb B, Touitou Y: Ramadan fasting alters endocrine and neuroendocrine circadian patterns. Meal-time as a synchronizer in humans? Life Sci 2001;68:1607-1615.
2. Aksungar FB, Eren A, Ure S, Teskin O, Ates G: Effects of intermittent fasting on serum lipid levels, coagulation status and plasma homocysteine levels. Ann Nutr Metab 2005;49:77-82.
3. Bogdan A, Bouchareb B, Touitou Y: Response of circulating leptin to Ramadan daytime fasting: a circadian study. Br J Nutr 2005;93:515-518.
4. Mohamed-Ali V, Goodrick S, Rawesh D, Katz DR, Miles JM, Yudkin JS, et al: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200.
5. Canavan B, Salem RO, Schurgin S, Koutkia P, Lipinska I, Laposata M, et al: Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J Clin Endocrinol Metab 2005;90:5779-5785.
6. Hakkou F, Tazi A, Iraki L: Ramadan et santé. Proc 1st Int Congr Health Ramadan, Casablanca, 1994, pp 31-61.
7. Selhub J: Homocysteine metabolism. Annu Rev Nutr 1999;19:217-246.
8. Gerdes VE, Hovinga HA, Ten Cate H, Mac-gillavry MR, Leijte A, et al: Homocysteine and markers of coagulation and endothelial cell activation. J Thromb Haemost 2004;2:445-451.
9. You T, Yang R, Lyles MF, Gong D, Nicklas BJ: Abdominal fat tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab 2005;288:E741-E747.
10. Konukoglu D, Hatemi H, Bayer H, Bagriacik N: Relationship between serum concentrations of interleukin-6 and tumor necrosis factor alpha in female Turkish subjects with normal and impaired glucose tolerance. Horm Metab Res 2006;38:34-37.
11. Muller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, et al: Impaired glucose tolerance is associated with increased serum concentrations of interleukin-6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologica 2002;45:805-812.
12. Corpeleijin E, Saris WHM, Jansen E, Roekaerts P, Feskens E, Blaak E: Postprandial interleukin-6 release from skeletal muscle in men with impaired glucose tolerance can be reduced by weight loss. J Clin Endocrinol Metab 2005;90:5819-5824.
13. Krumdieck CL, Prince CW: Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 2000;130:365S-368S.
14. Jakubowski H: Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 2000;130:377S-381S.
15. Dalal S, Parkins SM, Homer-Vanniasinkam S, Nicolaou A: Effect of homocysteine on cytokine production by human endothelial cells and monocytes. Ann Clin Biochem 2003;40:534-541.
16. Berg M, Fraker DL, Alexander HR: Characterisation of differentiation factor/leukemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes. Cytokine 1994;6:425-432.
17. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow Ro, Jablons D: Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin-6 in cancer cachexia. Cancer Res 1992;52:4113-4116.
18. Akgun S, Ertel NH, Mosenthal A, Oser W: Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response. J Lab Clin Med 1998;131:103-108.
19. Haddy N, Sass C, Droesch S, Zaiou M, Siest G, Ponthieux A, Lambert D, Visvikis S: IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003;170:277-283.
20. Onat A: Lipids, lipoproteins and apolipoproteins among Turks, and impact on coronary heart disease. Anadolu Kardiyol Derg 2004;4:236-245.
21. Kinosian B, Glick H, Garland G: Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994;121:641-647.
22. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847.
23. Magliano DJ, Liew D, Ashton EL, Sundararajan V, McNeil JJ: Novel biomedical risk markers for cardiovascular disease. J Cardiovasc Risk 2003;10:41-55.
24. Meier-Ewert H, Ridker P, Rifai N, Price N, Dinges DF, Mullington JM: Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001;47:426-430.
25. Sothern RB, Roitman-Johnson B, Kanabrocki EL, Yager JG, Rodell MM, Weatherbee JA, et al: Circadian characteristics of circulating interleukin-6 in men. J Allergy Clin Immunol 1995;95:1029-1035.
26. DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, et al: Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α) production in humans: high sensitivity of TNF-alpha and resistance to IL-6. J Clin Endocrinol Metab 1997;82:2182-2191.
27. Yudkin JS, Stehouwer CH, Emeis JJ, et al: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
28. Festa A, D'Agostino RJ, Howard G, et al: Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis study (IRAS). Circulation 2000;102:42-47.
29. Ridker PM, Wilson PWF, Grundy SM: Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004;109:2818-2825.